Erythromycin Lactobionate is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Nexus Pharamaceuticals Inc.. The primary component is Erythromycin Lactobionate.
| Product ID | 14789-116_c10e5a62-1ef9-47fa-becb-0d6a4f74177b |
| NDC | 14789-116 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Erythromycin Lactobionate |
| Generic Name | Erythromycin Lactobionate |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-08-01 |
| Marketing Category | ANDA / |
| Application Number | ANDA215290 |
| Labeler Name | Nexus Pharamaceuticals Inc. |
| Substance Name | ERYTHROMYCIN LACTOBIONATE |
| Active Ingredient Strength | 500 mg/10mL |
| Pharm Classes | Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |